Clinical Trials Directory

Trials / Conditions / Recurrent WHO Grade 2 Glioma

Recurrent WHO Grade 2 Glioma

6 registered clinical trials studyying Recurrent WHO Grade 2 Glioma — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTriapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
NCT06410248
Northwestern UniversityPhase 1
RecruitingTesting the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatmen
NCT05859334
National Cancer Institute (NCI)Phase 2
Active Not RecruitingSelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating
NCT04320888
National Cancer Institute (NCI)Phase 2
Active Not RecruitingA Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients Wi
NCT04576117
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alter
NCT04284774
National Cancer Institute (NCI)Phase 2
Active Not RecruitingIvosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutat
NCT04195555
National Cancer Institute (NCI)Phase 2